Intimation under Regulations 30 & 51 of SEBI (Listing Obligations andDisclosure Requirements) Regulations, 2015 Environmental, Social andGovernance (ESG) Rating
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma informed the stock exchanges that ISS ESG has voluntarily issued an ESG Corporate Rating Report for the company on June 3, 2025, based on publicly available data. The company has been assigned an overall ESG score of 38.98 with a rating of C-, which is considered below average on the ISS ESG scale. The company clarified that it has not verified the data used by ISS ESG for this rating. The disclosure was made under SEBI's Listing Obligations and Disclosure Requirements Regulations.
A C- ESG rating with a score of 38.98 is on the lower end and may be viewed negatively by ESG-focused institutional investors and funds that screen companies on sustainability criteria. However, since the rating was issued voluntarily on unverified data and Mankind is a pharma company, near-term stock price impact is likely limited.